Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003855 |
---|---|
Receipt number | R000004625 |
Scientific Title | Phase II study of cisplatin, pemetrexed plus bevacizumab for EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell lung cancer) |
Date of disclosure of the study information | 2010/07/01 |
Last modified on | 2013/03/13 14:53:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/07/01 19:07:19 | ||
2 | Update | 2010/08/02 16:32:54 | Interventions/Control_1 |
|
3 | Update | 2013/03/13 14:53:22 | Recruitment status |